new YORK (Reuters Health) – when the smokers than
are using nicotine patches are suffering a relapse,
they would be more likely to not go back to smoking if they continue using
these elements rather than abandon treatment, determined
a new Studio.
A team returned to analyze the results of a study
on the effectiveness of nicotine in smoking patches of
United States. The review included 509 participants that
had a relapse from the third to the fifth week of
treatment. (Means “ relapse” smoking just a
)(
cigarette).
The authors noted that users of the patches were
more likely than placebo ( control group) users to
“recovering”, i.e., to quit between the sixth
and the tenth week of treatment (8 percent versus less of the
1% of the control group).
“The effect is not very great.” “Does not leave us with his mouth
Open”, said Dr. Norman H. Edelman, medical director
of the American Association of the lungs and not
he participated in the study published in Addiction.
The specialist said that the study had limitations,
as a “secondary” analysis of a clinical trial that does not
was designed to respond if adhering to the therapies of
nicotine replacement improves recovery from relapses.
In addition, the study was conducted with funding from GlaxoSmithKline,
to produce the Nicoderm CQ patch and other therapies for replacement,
while the members of the team of Stuart Ferguson, of
the University of Tasmania, Australia, are consultants of the
pharmaceutical.
Edelman explained that the nicotine replacement therapies
help to stop smoking. As to the utility of continuing the
use of the patches after a relapse, said that there is
“a grey area”.
There is a concern that patients who smoke
while using the patch might suffer from an overdose of
nicotine. But the team Ferguson writes that some
studies found that holding therapy despite a relapse
would have “a small additional risk” adverse.
Hillel r. Alpert, researcher at the Center for Control
World of the tobacco of the Faculty of public health from Harvard,
it considered that one of the main limitations of the study
which focused on results in the short term. “Does not tell us
what about abstinence in the long-term”, said Alpert.
A month ago, the Alpert team published the results of
a study “in the real world”. There, concluded that therapy of
the nicotine replacement would not be as effective in the long
period.
“It is important to have a program of support to enable
“”
change the mentality and habits”, contended Edelman. Even so,
a battle to quit smoking is.
“A smoker makes five or six attempts before
“”
finally quit”, said Edelman.
Source: Addiction, online 26 January 2012.
